411 related articles for article (PubMed ID: 8761775)
21. Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
Leyden JJ; Nighland M; Rossi AB; Ramaswamy R
J Drugs Dermatol; 2010 Aug; 9(8):998-1003. PubMed ID: 20684151
[TBL] [Abstract][Full Text] [Related]
22. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
[TBL] [Abstract][Full Text] [Related]
23. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
Tu P; Li GQ; Zhu XJ; Zheng J; Wong WZ
J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():31-6. PubMed ID: 11843231
[TBL] [Abstract][Full Text] [Related]
24. Spotlight on adapalene in acne vulgaris.
Waugh J; Noble S; Scott LJ
Am J Clin Dermatol; 2004; 5(5):369-71. PubMed ID: 15554742
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.
Webster GF; Berson D; Stein LF; Fivenson DP; Tanghetti EA; Ling M
Cutis; 2001 Jun; 67(6 Suppl):4-9. PubMed ID: 11499329
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Goreshi R; Samrao A; Ehst BD
J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
[TBL] [Abstract][Full Text] [Related]
28. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
[TBL] [Abstract][Full Text] [Related]
29. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
Kakita L
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S51-4. PubMed ID: 10898831
[TBL] [Abstract][Full Text] [Related]
30. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.
Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S;
J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris.
Verschoore M; Langner A; Wolska H; Jablonska S; Czernielewski J; Schaefer H
Br J Dermatol; 1991 Apr; 124(4):368-71. PubMed ID: 1827344
[TBL] [Abstract][Full Text] [Related]
32. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
Gold LS; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
[TBL] [Abstract][Full Text] [Related]
33. Cumulative irritation potential of topical retinoid formulations.
Leyden JJ; Grossman R; Nighland M
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s14-8. PubMed ID: 18724650
[TBL] [Abstract][Full Text] [Related]
34. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
Pariser D; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s18-23. PubMed ID: 18575222
[TBL] [Abstract][Full Text] [Related]
35. Efficacy, safety, and tolerability of microsphere adapalene vs. conventional adapalene for acne vulgaris.
Rao GR; Ghosh S; Dhurat R; Sharma A; Dongre P; Baliga VP
Int J Dermatol; 2009 Dec; 48(12):1360-5. PubMed ID: 20415678
[TBL] [Abstract][Full Text] [Related]
36. Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
Leyden J; Wortzman M; Baldwin EK
J Drugs Dermatol; 2009 Apr; 8(4):383-8. PubMed ID: 19363857
[TBL] [Abstract][Full Text] [Related]
37. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study.
Kawashima M; Harada S; Loesche C; Miyachi Y
J Dermatol Sci; 2008 Mar; 49(3):241-8. PubMed ID: 18063345
[TBL] [Abstract][Full Text] [Related]
38. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
[TBL] [Abstract][Full Text] [Related]
39. Randomized facial tolerability studies comparing gel formulations of retinoids used to treat acne vulgaris.
Leyden J; Grove GL
Cutis; 2001 Jun; 67(6 Suppl):17-27. PubMed ID: 11499328
[TBL] [Abstract][Full Text] [Related]
40. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
Webster GF; Guenther L; Poulin YP; Solomon BA; Loven K; Lee J
Cutis; 2002 Feb; 69(2 Suppl):4-11. PubMed ID: 12095066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
